Seeing Lung Cancer Coming: 14 Proteins and the Rise of Promolytics
A new blood signature predicts lung cancer risk more than five years before diagnosis. Why a neurosurgeon who treats brain metastases is watching the promolytics movement.
Insights on brain health and neurosurgical advances
Insights on neurosurgery, brain health, and advances in cerebrovascular care
A new blood signature predicts lung cancer risk more than five years before diagnosis. Why a neurosurgeon who treats brain metastases is watching the promolytics movement.
How a missed FDA approval for VHL-associated brain tumors revealed the real gap between AI hype and what physicians actually need.
How GLP-1 receptor agonists are showing promise in treating IIH with rapid, sustained ICP reduction.
How neurosurgery has shifted from external clipping to endovascular flow diversion.
Reflections on why empathy and caring remain essential in medicine, even as AI advances.
Why image-guided surgery is essential for precision and safety in neurosurgery.